Parallel Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Parallel Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,000	Closed	-$24K	–	2791
2019 Q4	$24K	Buy	+4,000	New	+$23.2K	﹤0.01%	1331

Parallel Advisors's ACHN Position: Q1 2020 in Review

Parallel Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 4,000 shares — an estimated $24K sold.

Parallel Advisors first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $24K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Parallel Advisors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Parallel Advisors sold 4,000 Achillion Pharmaceuticals shares in Q1 2020, an estimated $24K.
Parallel Advisors first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Parallel Advisors's Achillion Pharmaceuticals position peaked at $24K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Parallel Advisors's 13F filing for Q1 2020, filed 27 Apr 2020.